[Pantogam in daily psychiatric practice].

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Medicine

Background:

• Neuroleptic medications are crucial for treating various neurological and psychiatric conditions.
• However, neuroleptic therapy often induces significant side-effects, including pathological muscle movements (extrapyramidal symptoms).
• Managing these adverse effects is essential for patient compliance and treatment efficacy.

Purpose of the Study:

• To evaluate the efficacy of Pantogam as a corrective agent for neuroleptic-induced side-effects.
• To assess the safety profile of Pantogam in patients undergoing neuroleptic therapy.
• To determine the potential of Pantogam in managing specific adverse motor symptoms.

Main Methods:

• A study involving 50 patients receiving neuroleptic therapy was conducted.
• Pantogam was administered at dosages ranging from 750 to 3000 mg daily.
• Psychometric scales were utilized to assess adverse effects, with a focus on pathological muscle movements.

Main Results:

• Pantogam demonstrated effectiveness in mitigating common side-effects associated with neuroleptic treatment.
• The drug was particularly successful in addressing pathological muscle movements.
• No negative impact on myocardial vessels was observed, and a mild sedative effect was noted.

Conclusions:

• Pantogam is an effective agent for correcting neuroleptic-induced side-effects, especially motor disturbances.
• Its favorable safety profile, including cardiovascular stability and mild sedation, supports its use.
• Pantogam's compatibility with other medications allows for its application across various age groups.